Overview

• Joby completed the deal on August 29 and may pay up to $45 million more in contingent consideration tied to performance and employee retention.
• The acquired unit is an air-charter brokerage with no aircraft of its own, including leased terminals in New York, Newark, Monte Carlo, Cannes and Nice.
• Blade divested the passenger arm, rebranded as Strata Critical Medical, and began trading under the SRTA ticker, with access to Joby aircraft for medical use.
• The passenger business generated $102 million in revenue and a $3.6 million profit in 2024 after a $5 million loss in 2023.
• Joby says the terminals and loyal flyers from Blade position it for faster commercial eVTOL service, though success depends on regulatory approval, aircraft availability and passenger acceptance.